EQUITY ALERT: Rosen Law Firm Announces Filing of Securities

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
223
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Qualcomm Incorporated - QCOM

NEW YORK, Feb. 08, 2017 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Qualcomm Incorporated securities (NASDAQ: QCOM ) from February 1, 2012 through January 17, 2017, both dates inclusive (the “Class Period”). The lawsuit seeks to recover damages for Qualcomm investors under the federal securities laws.

To join the Qualcomm class action, go to http://www.rosenlegal.com/cases-1030.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or kchan@rosenlegal.com for information on the class action.

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.

According to the lawsuit, throughout the Class Period Defendants made false and/or misleading statements and/or failed to disclose that: (1) Qualcomm was engaging and/or had engaged in anticompetitive conduct to maintain a monopoly for semiconductors used in mobile phones in violation of the FTC Act; (2) in turn, Qualcomm lacked effective internal controls over financial reporting; and (3) as a result, the Defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 24, 2017. If you wish to join the litigation, go to http://www.rosenlegal.com/cases-1030.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim or Kevin Chan of Rosen Law Firm toll free at 866-767-3653 or via email at pkim@rosenlegal.com or kchan@rosenlegal.com .

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm .

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.

Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. Kevin Chan, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 34th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 lrosen@rosenlegal.com pkim@rosenlegal.com kchan@rosenlegal.com www.rosenlegal.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 4

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading
Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 4

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 2

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 3

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 7

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 3

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 5

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 7

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading

Top 5 Most Recently Viewed Articles

ketteQ Raises $20M to Propel AI-Driven Supply Chain Solutions

Updated Category News Views 173

ketteQ Secures Significant Funding for Global Advancement Funding round supports ketteQ's mission to deliver adaptive planning, AI-powered insights, and measurable results in months, not years. ketteQ, a leader in adaptive supply chain planning solutions, has successfully raised $20 million in Series B funding, spearheaded by Vocap Partners. This fresh funding is set to...

Continue Reading
Cathie Wood's ARK Funds Make Strategic Moves in Tech Investments

Updated Category News Views 340

Overview of ARK's Recent Trading Activity Cathie Wood's ARK ETFs are well-known for their assertive trading strategies, and the most recent report reveals their latest stock moves. The firm has made headlines again by announcing a series of buy and sell transactions that display its ongoing commitment to innovation and growth in the tech sector. Let's dive into the...

Continue Reading
NEWTON GOLF Unveils $1 Million Share Repurchase Initiative

Updated Category News Views 119

NEWTON GOLF Announces Share Repurchase Authorization CAMARILLO, CA -- NEWTON GOLF Company (Nasdaq: SPGC), a leading innovator in the golf industry, has announced an authorization for a share repurchase program amounting to $1 million. This decision reflects a robust strategy to leverage market conditions and enhance shareholder value. The repurchase program will commence...

Continue Reading
Veritone Class Action: Stakes High for Shareholders

Updated Category News Views 3

Veritone's Legal Turbulence: Class Action Looms Alright, folks, here we go—a class action's got Veritone, Inc. (NASDAQ: VERI) in hot water, and it's not looking pretty. Legal eagles over at Robbins LLP are spearheading this suit, claiming the AI company botched its financial reporting. If you're holding VERI shares from October 14, 2025, through April 14, 2026, listen...

Continue Reading
TimelyCare Excellently Recognized for Mental Health Support

Updated Category News Views 180

TimelyCare Receives Prestigious Award for Mental Health Advocacy TimelyCare, known as higher education's most trusted virtual health and well-being provider, is honored to be recognized in the "Best in Business" list by Inc. for its exceptional advocacy in mental health. A Commitment to Student Health and Wellness As a winner in the Mental Health Advocacy category,...

Continue Reading